Projects per year
Personal profile
Headline
PROFESSOR | Medicine, Hematology and Medical Oncology
Biography
Dr. Tiersten is a Professor in the Division of Hematology and Medical Oncology and a member of the Breast Cancer Medical Oncology Program. Dr. Tiersten sees patients in the Dubin Breast Center. She works collaboratively with Mount Sinai breast surgeons, radiation oncologists, radiologists, and other related subspecialists to provide care to breast cancer patients and conduct breast cancer research. Dr. Tiersten has extensive experience participating clinical trials, as well as being the Principal Investigator for national studies.
Fingerprint
Dive into the research topics where Amy Tiersten is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 11 Finished
-
QUANTITATIVE MR IMAGING AND PROTON SPECTROSCOPY IN MULTIPLE SCLEROSIS
National Center for Research Resources
1/04/07 → 31/03/08
Project: Research
-
DOXIL COMBINED WITH DOCETAXEL IN PATIENTS WITH METASTATIC BREAST CANCER
National Center for Research Resources
1/04/06 → 31/03/07
Project: Research
-
QUANTITATIVE MR IMAGING AND PROTON SPECTROSCOPY IN MULTIPLE SCLEROSIS
National Center for Research Resources
1/04/06 → 31/03/07
Project: Research
-
DOXIL COMBINED WITH DOCETAXEL IN PATIENTS WITH METASTATIC BREAST CANCER
National Center for Research Resources
1/04/05 → 31/03/06
Project: Research
-
QUANTITATIVE MR IMAGING AND PROTON SPECTROSCOPY IN MULTIPLE SCLEROSIS
National Center for Research Resources
20/04/04 → 31/03/06
Project: Research
-
Correlation of the Ki67 Working Group prognostic risk categories with the Oncotype DX Recurrence Score in early breast cancer
Patel, R., Hovstadius, M., Kier, M. W., Moshier, E. L., Zimmerman, B. S., Cascetta, K., Jaffer, S., Sparano, J. A. & Tiersten, A., Oct 2022, In: Cancer. 128, 20, p. 3602-3609 8 p.Research output: Contribution to journal › Article › peer-review
-
Impact of body mass index on the efficacy of aromatase inhibitors in patients with metastatic breast cancer
Patel, R., Li, Z., Zimmerman, B. S., Fink, M. Y., Wells, J. D., Zhou, X., Ayers, K., Redfern, A., Newman, S., Schadt, E., Oh, W. K., Chen, R. & Tiersten, A., Apr 2022, In: Breast Cancer Research and Treatment. 192, 2, p. 313-319 7 p.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
Impact of the COVID-19 Pandemic on Cancer Care and Quality of Life for Patients With Breast and Gynecologic Malignancies: A Single-Center Survey-Based Study
Berger, N. F., Zimmerman, B. S., Seidman, D., Cascetta, K. P., Moshier, E., Nezolosky, M., Trlica, K., Ryncarz, A., Keeton, C. & Tiersten, A., Feb 2022, In: Journal of Patient Experience. 9Research output: Contribution to journal › Article › peer-review
Open Access -
Association of Insulin Resistance and Higher Oncotype DX™ Recurrence Score
Gordon, N. T., Alberty-Oller, J. J., Fei, K., Greco, G., Gallagher, E. J., LeRoith, D., Feldman, S. M., Killilea, B., Boolbol, S. K., Choi, L., Friedman, N., Pilewskie, M., Port, E., Tiersten, A. & Bickell, N. A., Oct 2021, In: Annals of Surgical Oncology. 28, 11, p. 5941-5947 7 p.Research output: Contribution to journal › Article › peer-review
2 Scopus citations -
Phase I/II trial of ruxolitinib in combination with trastuzumab in metastatic HER2 positive breast cancer
Kearney, M., Franks, L., Lee, S., Tiersten, A., Makower, D. F., Cigler, T., Mundi, P., Chi, D. C., Goel, A., Klein, P., Andreopoulou, E., Sparano, J., Trivedi, M., Accordino, M., Califano, A., Hershman, D. L., Silva, J. & Kalinsky, K., Aug 2021, In: Breast Cancer Research and Treatment. 189, 1, p. 177-185 9 p.Research output: Contribution to journal › Article › peer-review
7 Scopus citations
Press / Media
-
Early Change in Breast Cancer Tx Based on Genomic Testing Boosts PFS
21/12/21
1 item of Media coverage
Press/Media
-
Pyrotinib OS Benefit Confirmed in HER2-Positive Metastatic Breast Cancer
20/12/21
1 item of Media coverage
Press/Media
-
Pyrotinib plus chemotherapy may benefit patients with pretreated HER2-positive breast cancer
8/12/21
1 item of Media coverage
Press/Media
-
Early treatment switch may benefit patients with estrogen receptor mutations
7/12/21
1 item of Media coverage
Press/Media
-
Clinical Trial: Abemaciclib in Combination With Bicalutamide for Androgen Receptor-positive, HER2-negative Metastatic Breast Cancer
28/10/21
2 items of Media coverage
Press/Media